This has also been questioned by other findings: CEACAM1 is overexpressed in some malignancies including non-small cell lung cancer (Dango et al., 2008), melanoma (Ortenberg et al., 2014), gastric carcinoma (Zhou et al., 2009), and metastatic colon cancer (Ieda et al., 2011). Here, CEACAM1 is linked to non-small cell lung carcinoma.